Literature DB >> 17216423

Penetration of levofloxacin into the anterior chamber (aqueous humour) of the human eye after intravenous administration.

E García-Vázquez1, J Mensa, M Sarasa, Y López, P D Couchard, D Soy, J R Fontenla.   

Abstract

In the study presented here, levofloxacin concentrations in serum samples and the aqueous humour (AH) of 16 patients undergoing cataract extraction were measured in order to determine the penetration characteristics of levofloxacin into the AH of the non-inflamed human eye. Cataract removal was performed at various times (from 90 to 270 min) after the end of a 30-min intravenous infusion of 500 mg of levofloxacin. Serum samples were obtained 1 h after the end of levofloxacin administration (Cmax); AH and a second serum sample were taken simultaneously during the operation, and the concentrations of levofloxacin in AH (C(AH)) and serum (C(S)) were determined using a rapid high-performance liquid chromatography assay. The mean Cmax was 6.07 microg/ml (range 3.75-9.53 microg/ml, SD 1.83). The mean C(AH) at the first hour following levofloxacin administration was 1.37 microg/ml (range 1.17-1.6 microg/ml, SD 0.22) and the mean ratio (R=C(AH)/C(S)) was 0.26 (range 0.24-0.3, SD 0.02). The mean C(AH) at 125-270 min following levofloxacin administration was 1.39 microg/ml (range 0.82-1.98 microg/ml, SD 0.33) and the mean R was 0.3 (range 0.15-0.53, SD 0.11). Of 16 patients, 15 had a C(AH) of >1 microg/ml 1 h after levofloxacin administration. In conclusion, 1 h after administration of 500 mg of levofloxacin, the levels obtained were higher than the MIC at which 90% of methicillin-susceptible Staphylococcus aureus and certain gram-negative bacteria strains are inhibited.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17216423     DOI: 10.1007/s10096-006-0241-9

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  13 in total

1.  Penetration of topical and oral ciprofloxacin into the aqueous and vitreous humor in inflamed eyes.

Authors:  F Oztürk; S Kortunay; E Kurt; S S Ilker; N E Basci; A Bozkurt
Journal:  Retina       Date:  1999       Impact factor: 4.256

2.  Aqueous and vitreous penetration of levofloxacin after oral administration.

Authors:  R G Fiscella; T K Nguyen; M J Cwik; B A Phillpotts; S M Friedlander; D C Alter; M J Shapiro; N P Blair; J P Gieser
Journal:  Ophthalmology       Date:  1999-12       Impact factor: 12.079

3.  The effect of trauma on the ocular penetration of intravenous ciprofloxacin.

Authors:  D V Alfaro; S J Hudson; M M Rafanan; S T Moss; S D Levy
Journal:  Am J Ophthalmol       Date:  1996-11       Impact factor: 5.258

4.  Intravitreal penetration of oral ciprofloxacin in humans.

Authors:  F Z el Baba; M D Trousdale; W J Gauderman; D G Wagner; P E Liggett
Journal:  Ophthalmology       Date:  1992-04       Impact factor: 12.079

Review 5.  Fluoroquinolones: place in ocular therapy.

Authors:  A Smith; P M Pennefather; S B Kaye; C A Hart
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 6.  The clinical pharmacokinetics of levofloxacin.

Authors:  D N Fish; A T Chow
Journal:  Clin Pharmacokinet       Date:  1997-02       Impact factor: 6.447

7.  Pharmacokinetics of ciprofloxacin in the human eye: a clinical study and population pharmacokinetic analysis.

Authors:  N Morlet; G G Graham; B Gatus; A J McLachlan; C Salonikas; D Naidoo; I Goldberg; C M Lam
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

8.  The penetration of oral ciprofloxacin into the aqueous humor, vitreous, and subretinal fluid of humans.

Authors:  M R Lesk; H Ammann; G Marcil; B Vinet; L Lamer; M Sebag
Journal:  Am J Ophthalmol       Date:  1993-05-15       Impact factor: 5.258

9.  Nosocomial acute-onset postoperative endophthalmitis survey. A 10-year review of incidence and outcomes.

Authors:  T M Aaberg; H W Flynn; J Schiffman; J Newton
Journal:  Ophthalmology       Date:  1998-06       Impact factor: 12.079

10.  Human vitreous levels of selected antistaphylococcal antibiotics.

Authors:  J L Axelrod; R M Klein; R L Bergen; M Z Sheikh
Journal:  Am J Ophthalmol       Date:  1985-10-15       Impact factor: 5.258

View more
  1 in total

1.  Sequential Intravenous-Oral Therapy for Pediatric Streptococcus anginosus Intracranial Infections.

Authors:  Daniel S Dodson; Heather R Heizer; James T Gaensbauer
Journal:  Open Forum Infect Dis       Date:  2022-01-06       Impact factor: 3.835

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.